Eco Animal Health Group (LON:EAH) Given “Buy” Rating at Peel Hunt

Peel Hunt reaffirmed their buy rating on shares of Eco Animal Health Group (LON:EAH) in a research note released on Thursday morning, ThisIsMoney.Co.Uk reports.

EAH opened at GBX 410 ($5.36) on Thursday. The company has a quick ratio of 3.04, a current ratio of 4.09 and a debt-to-equity ratio of 1.76. Eco Animal Health Group has a 1-year low of GBX 90 ($1.18) and a 1-year high of GBX 755 ($9.87). The company has a market capitalization of $276.82 million and a P/E ratio of 23.70. The stock has a 50 day simple moving average of GBX 387.70.

The firm also recently declared a dividend, which will be paid on Wednesday, October 16th. Shareholders of record on Thursday, September 26th will be given a GBX 7.04 ($0.09) dividend. The ex-dividend date of this dividend is Thursday, September 26th. This is an increase from Eco Animal Health Group’s previous dividend of $3.50. This represents a yield of 1.96%. Eco Animal Health Group’s dividend payout ratio (DPR) is presently 0.87%.

Eco Animal Health Group Company Profile

ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.

Recommended Story: Asset Allocation Models, Which is Right For You?

Receive News & Ratings for Eco Animal Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eco Animal Health Group and related companies with's FREE daily email newsletter.